Duan Yan-Wen, Huang Ying, Cai Li-Qun, Duan Quwen, Zhu Yuan-Shan
Changsha Cihang Research Institute of Materia Medica, Changsha, Hunan 410011, China.
Oncol Rep. 2007 Jun;17(6):1391-7.
Tumor metastasis is the leading cause of cancer death. In the present study, we determined the effectiveness of ZYD88, a Chinese herbal formula, in the inhibition of tumor growth and distant tumor metastases to the lung and liver in an animal model with metastatic Lewis lung carcinoma (LLC). Treatment with ZYD88 in adult C57BL/6 mice with metastatic LLC produced dose-dependent deceases in primary tumor weight, the mitotic tumor cell number, microvessel density, distant tumor metastases and red blood cell immune complexes, while it significantly increased tumor necrosis, thymus cortical thickness, the thymus medullar reticular epithelial cell (REC) number, and the activity of red blood cell C3b receptors. Although cyclophosphamide inhibited tumor growth, it had no significant effects on distant tumor metastases, thymus cortical thickness, the thymus medullar REC number, red blood cell C3b receptor activity and red blood cell immune complexes. These results indicate that ZYD88 possesses significant anti-angiogenic, anti-tumor and anti-metastatic effects in this animal model, and warrants further investigation.
肿瘤转移是癌症死亡的主要原因。在本研究中,我们在具有转移性Lewis肺癌(LLC)的动物模型中,确定了中药配方ZYD88在抑制肿瘤生长以及远处肿瘤向肺和肝转移方面的有效性。用ZYD88治疗患有转移性LLC的成年C57BL/6小鼠,可使原发肿瘤重量、有丝分裂肿瘤细胞数量、微血管密度、远处肿瘤转移和红细胞免疫复合物呈剂量依赖性降低,同时显著增加肿瘤坏死、胸腺皮质厚度、胸腺髓质网状上皮细胞(REC)数量以及红细胞C3b受体的活性。虽然环磷酰胺抑制肿瘤生长,但对远处肿瘤转移、胸腺皮质厚度、胸腺髓质REC数量、红细胞C3b受体活性和红细胞免疫复合物没有显著影响。这些结果表明,ZYD88在该动物模型中具有显著的抗血管生成、抗肿瘤和抗转移作用,值得进一步研究。